Nirmatrelvir-ritonavir may lower risk of intubation or in-hospital mortality in patients with severe COVID-19.
Meaningful reduction in symptoms seen for some taking an extended course outside of the context of an acute infection. HealthDay News — Extended-course nirmatrelvir/ritonavir yields a meaningful ...
New research highlights the effectiveness of nirmatrelvir-ritonavir in lowering hospitalization rates and long COVID symptoms in non-hospitalized, high-risk COVID-19 patients. Study: Nirmatrelvir plus ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results